Personality and Incident Alzheimer's Disease: Theory, Evidence, and Future Directions

被引:30
|
作者
Segerstrom, Suzanne C. [1 ]
机构
[1] Univ Kentucky, Dept Psychol, 125 Kastle Hall, Lexington, KY 40506 USA
关键词
Alzheimer's dementia; Conscientiousness; Health behavior; Neuroticism; Personality; LEADING BEHAVIORAL CONTRIBUTORS; MILD COGNITIVE IMPAIRMENT; RISK; TRAITS; OLDER; DEMENTIA; LIFE; CONSCIENTIOUSNESS; MORTALITY; ONSET;
D O I
10.1093/geronb/gby063
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Personality, especially the dimensions of neuroticism and conscientiousness, has prospectively predicted the risk of incident Alzheimer's disease (AD). Such a relationship could be explained by personality and AD risk having a common cause such as a gene; by personality creating a predisposition for AD through health behavior or inflammation; by personality exerting a pathoplastic effect on the cognitive consequences of neuropathology; or by AD and personality change existing on a disease spectrum that begins up to decades before diagnosis. Using the 5-dimensional taxonomy of personality, the present review describes how these models might arise, the evidence for each, and how they might be distinguished from one another empirically. At present, the evidence is sparse but tends to suggest predisposition and/or pathoplastic relationships. Future studies using noninvasive assessment of neuropathology are needed to distinguish these 2 possibilities.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 50 条
  • [1] Neuroinflammation in Alzheimer's disease: Current evidence and future directions
    Calsolaro, Valeria
    Edison, Paul
    ALZHEIMERS & DEMENTIA, 2016, 12 (06) : 719 - 732
  • [2] Future directions in the treatment of Alzheimer's disease
    Bullock, R
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (04) : 303 - 314
  • [3] Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
    Schioth, Helgi B.
    Craft, Suzanne
    Brooks, Samantha J.
    Frey, William H., II
    Benedict, Christian
    MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 4 - 10
  • [4] Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
    Helgi B. Schiöth
    Suzanne Craft
    Samantha J. Brooks
    William H. Frey
    Christian Benedict
    Molecular Neurobiology, 2012, 46 : 4 - 10
  • [5] Treatment of Alzheimer's disease: Future directions
    Wilcock, GK
    Harrold, PL
    ACTA NEUROLOGICA SCANDINAVICA, 1996, 93 : 128 - 136
  • [6] Future directions in animal models of Alzheimer's disease
    Beckman, Danielle
    Baxter, Mark G.
    Morrison, John H.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2018, 96 (12) : 1829 - 1830
  • [7] Status and future directions of clinical trials in Alzheimer's disease
    Plascencia-Villa, German
    Perry, George
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 3 - 50
  • [8] Passive immunotherapy for Alzheimer's disease: challenges & future directions
    Yi, Ling Xiao
    Tan, Eng King
    Zhou, Zhi Dong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [9] Immunotherapy in Alzheimer's Disease: Current Status and Future Directions
    Vashisth, Kshitij
    Sharma, Shivani
    Ghosh, Shampa
    Babu, M. Arockia
    Ghosh, Soumya
    Iqbal, Danish
    Kamal, Mehnaz
    Almutary, Abdulmajeed G.
    Jha, Saurabh Kumar
    Ojha, Shreesh
    Bhaskar, Rakesh
    Jha, Niraj Kumar
    Sinha, Jitendra Kumar
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 101 : S23 - S39
  • [10] Handedness in Alzheimer's Disease: A Systematic Review and Future Directions
    Guido, Giorgio
    Bonato, Alberto
    Bonomi, Samuele
    Franceschini, Simone
    Morris, John C.
    ANNALS OF NEUROLOGY, 2023, 94 : S78 - S79